Company Filing History:
Years Active: 2025
Title: Murielle M Venient-Ellison: Innovator in Metabolic Disorder Treatments
Introduction
Murielle M Venient-Ellison is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of metabolic disorder treatments. Her innovative work focuses on utilizing GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) to address various metabolic diseases.
Latest Patents
Murielle holds 1 patent for her invention titled "Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)." This patent provides methods for treating metabolic diseases and disorders using a composition that includes an antigen binding protein specific for the GIPR polypeptide. The invention is particularly relevant for conditions such as type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy. The composition may comprise an antibody or functional fragment that includes a cysteine at one or more conjugation sites, allowing for the GLP-1 receptor agonist to be conjugated through the side-chain of the cysteine residue.
Career Highlights
Murielle is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to focus on innovative solutions for metabolic disorders, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Murielle has collaborated with notable colleagues, including Yuan Cheng and Chawita Netirojjanakul. These collaborations have further enhanced her research and development efforts in the field of metabolic disorders.
Conclusion
Murielle M Venient-Ellison is a dedicated inventor whose work has the potential to significantly impact the treatment of metabolic disorders. Her innovative approaches and collaborations continue to drive advancements in this important area of healthcare.